Skip to main content

Good evening, here are the COVID-19 updates you need to know tonight.

Top headlines:

  1. Canada’s top doctor, Theresa Tam, underlines need for COVID-19 rapid tests and boosters to help control another wave as the Omicron variant escalates
  2. How an inhaled COVID-19 vaccine might breathe life into the fight against the pandemic
  3. Two COVID-19 vaccine doses not enough to fight off increased infections from Omicron variant, U.K. study finds

In the past seven days, 28,813 cases were reported, up 31 per cent from the previous seven days. There were 146 deaths announced, up 15 per cent over the same period. At least 1,312 people are being treated in hospitals.

Canada’s inoculation rate is 21st among countries with a population of one million or more people.

Open this photo in gallery:

Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopening


Photo of the day

Open this photo in gallery:

People queue outside a vaccination centre in Manchester, England, today. British Prime Minister Boris Johnson announced a huge increase in booster vaccinations to strengthen defenses against the Omicron variant.Jon Super/The Associated Press


Coronavirus in Canada


Canada’s Chief Public Health Officer, Theresa Tam, said today that Canada is about to experience a major surge in COVID-19 cases and that health officials need to step up the use of rapid antigen tests, booster shots and other public-health tools in order to prevent closings, lockdowns and overwhelmed hospitals.

  • In a press briefing, Tam said she expects cases of the Omicron variant to “rapidly escalate” in the coming days.
  • Also, as part of her annual report, which was tabled in the House of Commons today, Tam said gaps in Canada’s ability to collect data about the pandemic hindered the country’s response.

Inhaled COVID-19 vaccine: A pair of COVID-19 vaccines developed at McMaster University, in Hamilton, Ont., are designed to be inhaled as a fine mist that is deposited into subjects’ lungs. It could be a game- changer in the coronavirus fight.

Unvaccinated family and friends: Around one in ten people surveyed by Leger in a poll commissioned by the Association for Canadian Studies said they no longer speak to or associate with their contacts who are unvaccinated.

Postponed in-person exams: Some Canadian postsecondary institutions, including the University of Victoria and Queen’s University, are postponing in-person exams in response to the rise of COVID-19 cases.


Coronavirus around the world


Coronavirus and business

COVID-19 vaccine maker Pfizer said on Monday it will buy Arena Pharmaceuticals for $6.7-billion in cash to add a promising treatment candidate that targets diseases affecting the stomach and intestine.

  • Arena is developing several treatments for gastroenterology, dermatology and cardiology. Its lead candidate, etrasimod, is being tested in a late-stage study in ulcerative colitis, a type of inflammatory bowel disease that causes ulcers in the digestive tract.

Also today: Oil falls as new concerns about Omicron COVID-19 variant weigh on prices


Globe opinion


More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? E-mail us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe